Report

Global High Intensity Focused Ultrasound Market Size study, by Application, by End-use, and Regional Forecasts 2022-2032

  • Publish Date: Sep,2024
  • Report ID: 3-1-1861
  • Page : 200
  • Report Type : PDF (Email)
Global High Intensity Focused Ultrasound (HIFU) Market is valued at approximately USD 1.23 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.06% over the forecast period 2024-2032. High Intensity Focused Ultrasound (HIFU) is a revolutionary non-invasive therapeutic technique that utilizes concentrated ultrasound waves to produce localized heat, effectively destroying diseased tissue. Predominantly used in cancer treatments such as prostate and liver cancer, HIFU operates by focusing high-frequency sound waves on targeted areas, inducing cellular destruction through thermal and mechanical effects. This precise method minimizes harm to surrounding healthy tissues and offers fewer side effects compared to traditional surgical procedures, making it a compelling alternative in contemporary medical treatments.

The HIFU market's growth is driven by several pivotal factors, including the escalating prevalence of cancer and other chronic disorders, the rising preference for minimally invasive procedures, advancements in technology, and the expanding use of HIFU in non-oncological applications. There's a growing preference for minimally invasive procedures, which HIFU offers. Technological advancements enhance its efficacy and safety, making it more attractive. Additionally, the expanding use of HIFU in non-oncological applications, such as cosmetic procedures and treatment of benign diseases, broadens its market potential, driving further growth. However, high cost of HIFU systems is going to impede the overall demand for the market during the forecast period 2024-2032.

The key regions considered for the market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the HIFU market in 2023, capturing the largest revenue share. This regional supremacy is attributed to the presence of key market players and ongoing research and development activities. Additionally, the high prevalence of chronic diseases, including cancer, in North America drives the demand for effective and less invasive treatment methods such as HIFU, further bolstering market growth. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market players included in this report are:
Focal One
Sonablate Corp.
Verasonics, Inc.
ALPINION MEDICAL SYSTEMS Co., Ltd.
Theraclion
Chongqing Haifu Medical Technology Co., Ltd.
Lynton Lasers Ltd
ULTRAISER
Profound Medical Inc
The detailed segments and sub-segments of the market are explained below:
By Application:
Uterine Fibroids
Prostate Cancer
Essential Tremor
Dermatology
Breast Cancer
Glaucoma
Backpain, Facetogenic
Other Applications
By End-use:
Hospitals
Imaging Centers
Other End Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market